“Tradipitant: A Novel NK-1 Receptor Antagonist for the Management of Motion Sickness- A New Era in Drug Development”. International Journal of Research in Pharmaceutical Sciences and Technology, vol. 9, no. 3, Aug. 2026, https://doi.org/10.33974/xxyc9n51.